Zobrazeno 1 - 10
of 169
pro vyhledávání: '"IVAN M ROBBINS"'
Autor:
Evan L Brittain, Meredith E Pugh, Li Wang, Alex L Newman, Ivan M Robbins, John H Newman, Anna R Hemnes
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e76461 (2013)
BACKGROUND:Differentiation of pulmonary arterial hypertension (PAH) and pulmonary venous hypertension (PVH) often requires right heart catheterization (RHC). We sought to determine whether a combination of clinical and echocardiographic variables cou
Externí odkaz:
https://doaj.org/article/d207738279504df9a81cc8dfc48bcc9e
Autor:
Anil J. Trindade, MD, Kaitlyn C. Chapin, AGNP-C, CCTC, Jennifer N. Gray, PharmD, Yuka Furuya, MD, MSCI, Amy Mullican, RN, Haley Hoy, ACNP, PhD, Caitlin T. Demarest, MD, PhD, Ivan M. Robbins, MD, Matthew Bacchetta, MD, MBA, David B. Erasmus, MD, Ciara M. Shaver, MD, PhD
Publikováno v:
Transplantation Direct, Vol 9, Iss 6, p e1487 (2023)
Background. Donor-derived cell-free DNA (dd-cfDNA%) is a biomarker of early acute lung allograft dysfunction (ALAD), with a value of ≥1.0% indicating injury. Whether dd-cfDNA% is a useful biomarker in patients >2 y posttransplant is unknown. Our gr
Externí odkaz:
https://doaj.org/article/711fae669f77454abf6c75532b107e48
Autor:
Anil J. Trindade, MD, Kaitlyn C. Chapin, AGNP, Amy Mullican, RN, Jennifer N. Gray, PharmD, Haley Hoy, AGNP, PhD, Caitlin T. Demarest, MD, PhD, Eric S. Lambright, MD, Katie A. McPherson, MD, Stephanie G. Norfolk, MD, Ivan M. Robbins, MD, Matthew Bacchetta, MD, MBA, David B. Erasmus, MD, Ciara M. Shaver, MD, PhD
Publikováno v:
Transplantation Direct, Vol 8, Iss 12, p e1411 (2022)
Background. Donor-derived cell-free DNA (dd-cfDNA) is a useful biomarker for the diagnosis of acute allograft injury within the first 1 to 2 y after lung transplant, but its utility for diagnosing chronic lung allograft dysfunction (CLAD) has not yet
Externí odkaz:
https://doaj.org/article/f0292f4e8b434720bba0eed3fe2670f5
Autor:
Anil J. Trindade, MD, Whitney D. Gannon, MS, MSN, John W. Stokes, MD, Eric S. Lambright, MD, Katie A. McPherson, MD, Stephanie G. Norfolk, MD, Ivan M. Robbins, MD, Ciara M. Shaver, MD, PhD, Matthew Bacchetta, MD, MBA
Publikováno v:
Transplantation Direct, Vol 8, Iss 10, p e1371 (2022)
Externí odkaz:
https://doaj.org/article/b8473b33ef7d4668b64675b21b711cc8
Autor:
Evan L. Brittain, Kevin Niswender, Vineet Agrawal, Xinping Chen, Run Fan, Meredith E. Pugh, Todd W. Rice, Ivan M. Robbins, Haocan Song, Christopher Thompson, Fei Ye, Chang Yu, He Zhu, James West, John H. Newman, Anna R. Hemnes
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 22 (2020)
Background Metabolic dysfunction is highly prevalent in pulmonary arterial hypertension (PAH) and likely contributes to both pulmonary vascular disease and right ventricular (RV) failure in part because of increased oxidant stress. Currently, there i
Externí odkaz:
https://doaj.org/article/6afa9ff7a56e4bc1a57e9254ceab5a30
Autor:
Vineet Agrawal, Michele D'Alto, Robert Naeije, Emanuele Romeo, Meng Xu, Tufik R. Assad, Ivan M. Robbins, John H. Newman, Meredith E. Pugh, Anna R. Hemnes, Evan L. Brittain
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 17 (2019)
Background Identification of occult diastolic dysfunction often requires invasive right heart catheterization with provocative maneuvers such as fluid challenge. Non‐invasive predictors of occult diastolic dysfunction have not been identified. We h
Externí odkaz:
https://doaj.org/article/25e449f7e94d4f39b3ad78611b7c3b84
Autor:
Vallerie V. McLaughlin, Sonia Jain, Victor Test, Myung H Park, Feng He, Ivan M. Robbins, R. Duane Davis, Raymond L. Benza, Kelly Chin, Victor F. Tapson, Kim M. Kerr, Richard N. Channick, Michael M. Madani, Andrea Z. LaCroix, William R. Auger, C. Greg Elliott, Jeffrey R. Terry
Publikováno v:
Chest. 160:1822-1831
BACKGROUND The United States Chronic Thromboembolic Pulmonary Hypertension Registry (US-CTEPH-R) was designed to characterize the demographic characteristics, evaluation, clinical course, and outcomes of surgical and nonsurgical therapies for patient
Autor:
Anil J. Trindade, Kaitlyn C. Chapin, Whitney D. Gannon, Haley Hoy, Caitlin T. Demarest, Eric S. Lambright, Katie A. McPherson, Stephanie G. Norfolk, Ivan M. Robbins, Matthew Bacchetta, David B. Erasmus, Ciara M. Shaver
Publikováno v:
Transplant infectious disease : an official journal of the Transplantation SocietyREFERENCES. 24(6)
Reports on outcomes following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in lung transplant recipients remain limited.We performed a single-center, observational study of outcomes in lung transplant recipients diagnosed wi
Autor:
Eric D. Austin, Nicholas S. Hill, Zeenat Safdar, Robert W. Simms, Abby Poms, William C. Nichols, Harrison W. Farber, Katie A. Lutz, K. Feldkircher, Robert P. Frantz, Terry Fortin, J. Badlam, R. James White, Charles D. Burger, Jean M. Elwing, Murali M. Chakinala, Raymond L. Benza, C. Gregory Elliott, Wendy K. Chung, Ivan M. Robbins, Michael W. Pauciulo, Chang Yu, Marc A. Simon, Sophia Airhart, David B. Badesch, Adaani E. Frost
Publikováno v:
Chest. 159:311-327
Background The treatment, genotyping, and phenotyping of patients with World Health Organization Group 1 pulmonary arterial hypertension (PAH) have evolved dramatically in the last decade. Research Question The United States Pulmonary Hypertension Sc
Autor:
ASHLEY DRENGLER, CIARA M SHAVER, ALEXIS GOREE, IVAN M ROBBINS, STEPHANIE NORFOLK, KATIE A MCPHERSON, ANIL TRINDADE, DAVID B ERASMUS, ERIC LAMBRIGHT, CAITLIN DEMAREST, MATTHEW BACCHETTA
Publikováno v:
Chest. 162:A2577-A2578